Matthew B. Klein - 05 Jan 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
05 Jan 2023
Transactions value $
$0
Form type
4
Filing time
09 Jan 2023, 15:52:57 UTC
Previous filing
27 May 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Award $0 +26K +45.53% $0.00 83.1K 05 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +65K $0.00 65K 05 Jan 2023 Common Stock 65K $39.42 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024.
F2 Includes 263 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 277 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022.
F3 This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.